Showing 881-890 of 9295 results for "".
DermWire TV: Factors Affecting Long-term Antibiotic Prescriptions for Acne; Biologics Firm Focusing on Plaque Psoriasis Makes an Important Acquisition; Practical Dermatology Launches Two New Video Series
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-factors-affecting-long-term-antibiotic-prescriptions-acne-biologics-firm-focusing-plaque-psoriasis-makes-important-acquisition-practical-dermatology-launches-two-new-video-series/24319/In this episode of DermWire TV, a new analysis highlights factors affecting long-term antibiotic prescriptions for acne; a company developing plaque psoriasis biologics makes a major acquisition; and Practical Dermatology® launches two new video series focusing on advancing treatment and improving uDermWireTV: Qwo Approved, Assessing Resident Anxiety
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-qwo-approved-assessing-resident-anxiety/19830/FDA has approved Qwo (collagenase clostridium histolyticum-aaes) from Endo, the first injectable treatment approved for moderate to severe cellulite in the buttocks of adult women. A recent survey offers perspective on anxiety among third-year dermatology residents in light of the COVID crisis. AlleDermWireTV: Practices Reopen; Prescriber's Choice Expands; Sun Takes on Acne
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-practices-reopen-prescribers-choice-expands-sun-takes-on-acne/19810/Dermatology practices across the US are re-opening and professional associations are offering guidance, as states reduce restrictions. From Prescriber's Choice comes PC Direct for in-office use and PC Delivers for remote prescribing. Sun Dermatology’s Take on Acne advertising campaign is raising awaDifferentiating Atopic Dermatitis From Psoriasis and CTCL
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/differentiating-atopic-dermatitis-from-psoriasis-and-ctcl/48778/Christopher Bunick, MD, FAAD, discusses the overlap in gene expression and cytokine signaling between atopic dermatitis and psoriasis, the possibility of CTCL mimicking atopic dermatitis, and the utility of a skin biopsy in some cases to differentiate.DermWire TV: Kysse Approved, Sunscreen Use Trends, AbbVie/Allergan Deal
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwire-tv-kysse-approved-sunscreen-use-trends-abbvieallergan-deal/19812/Galderma's Restylane Kysse is now FDA approved for lip augmentation and the correction of wrinkles around the upper lips in adults. Americans understand that sunscreen use is important to protect the skin, but they still don’t use SPF regularly, AAD data reveal. AbbVie has completed its acquisitionHow Incyte Is Following the Science to Address Unmet Needs in Immune-Mediated Skin Conditions
https://practicaldermatology.com/topics/infections-infectious-disease/how-incyte-is-following-the-science-to-address-unmet-needs-in-immune-mediated-skin-conditions/19945/Ahmad Naim, MD, Vice President of US Medical Affairs at Incyte, shares how the company’s discovery expertise in immunology is fueling research aimed at delivering innovative medicines that address the unmet needs of people living with immune-mediated dermatologic conditions, including atopic dermatiDermWireTV: Inclusion in Derm; Amgen, Incyte, Janssen, Dermavant Updates; Klisyri Launch; More
https://practicaldermatology.com/topics/practice-management/dermwiretv-inclusion-in-derm-amgen-incyte-janssen-dermavant-updates-klisyri-launch-more/19901/For an article in Pediatric Dermatology, Linda Oyesiku, MPH, a student member of the Society for Pediatric Dermatology, describes historical obstacles to inclusion and highlights opportunities to expand representation and reduce bias in dermatology. Research conducted by The Martec Group using theirMechanisms of Action for IL-17 Inhibition in Treating Psoriasis and Hidradenitis Suppurativa
https://reachmd.com/programs/practical-dermatology-il-17-journal-club/mechanisms-of-action-for-il-17-inhibition-in-treating-psoriasis-and-hidradenitis-suppurativa/48808/Practical Dermatology Editorial Board member Jason E. Hawkes, MD, MS, FAAD, joins Chief Medical Editor Neal Bhatia, MD, FAAD, to discuss articles from the Journal of Clinical Medicine and Clinics in Dermatology on how IL-17 inhibition is effective in treating psoriasis and hidradenitis suppurativa,Dermwire TV Extra: The Global Access to Skin Health Observatory
https://practicaldermatology.com/series/dermwire-tv/global-access-skin-health-observatory/29873/Esther Freeman, MD, PhD, Director of Global Health Dermatology at Massachusetts General Hospital and Harvard Medical School, and Vice Chair of the International Foundation of Dermatology with the International League of Dermatological Societies (ILDS), talks with Practical Dermatology about her workTrends in the Medical Aesthetic Market
https://practicaldermatology.com/series/c-suite-chats/trends-in-the-medical-aesthetic-market/24560/Ethan Min, CEO of Benev, discusses trends in the medical aesthetic market, including the potential impact that Glucagon-like peptide-1 (GLP-1) for weight loss will have on the aesthetics industry.